OREM, UT--(Marketwire - June 16, 2009) - Reflect Scientific, Inc. (OTCBB: RSCF) announces that Cryometrix, a wholly owned subsidiary of Reflect Scientific, has successfully completed a collaborative evaluation with a major pharmaceutical company and is moving towards implementation of its T-150 cryogenic processing system.
The Cryometrix T-150 technology will be deployed to eliminate manufacturing bottlenecks and its implementation is expected to result in greatly enhanced production efficiencies compared to those resulting from the use of traditional mechanical freezer units.
“The execution of this phase one installation program follows an 18 month rigorous evaluation, which successfully demonstrated the validatable performance of the T-150 cryogenic process. The T-150 out-performed its mechanical counterpart and exceeded customer expectations. Through deployment of the T-150 technology our client will have the potential to realize a very significant increase in capacity per unit installed. We have clearly proven the T-150 can complete cryogenic freezing tasks in hours that previously took days and will therefore result in significant added value for our customers,” remarked Dr. Boyd Bowdish, Director and Principal Scientist for Cryometrix.
About Cryometrix
Cryometrix develops, manufactures and markets cryopreservation equipment. The Cryometrix Ultra Low Temperature model T-150 freezer is an “all-in-one” cryogenic freezing system. It is the first liquid nitrogen-based (LN2), programmable cryogenic freezing system in a standard upright format, which allows for exceptional reliability, precise thermal uniformity and no user or product exposure to liquid nitrogen. The Cryometrix T-150 freezer is optimized for bio-repositories, research, forensic, hospital and clinical laboratories, and other life science applications where refrigeration and cryogenic preservation is required. Cryometrix is a wholly owned subsidiary of Reflect Scientific, Inc. For more information, go to www.cryometrix.com.
About Reflect Scientific, Inc.
Reflect Scientific, Inc. and its subsidiaries provide products for life science, biotechnology and pharmaceutical industries, as well as tools and analytical services for industrial manufacturing. For more information, visit www.reflectscientific.com.
Cautionary Note Regarding Forward-Looking Statements:
Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company’s products, increased levels of competition for the company, new products and technological changes, the company’s dependence on third-party suppliers, and other risks detailed from time to time in the company’s periodic reports filed with the Securities and Exchange Commission.
Investor Relations Contact:
Michael Dancy
801-746-3570
Email Contact
